Using AI to improve imaging for pulmonary embolism diagnosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study in China that aims to enhance the diagnosis and management of pulmonary embolism (PE) through advanced imaging techniques and artificial intelligence. By collecting and analyzing imaging data from patients suspected of PE, the study seeks to identify key imaging markers that can aid in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment. The study focuses on the critical stages of PE, including acute pulmonary embolism, chronic thromboembolic pulmonary disease, and chronic thromboembolic pulmonary hypertension, to improve patient outcomes through timely intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 14 Years and older
* Patients suspected of PE

Exclusion Criteria:

* Pregnant women
* Refuse to follow up
* Incomplete or discontinued imaging scans
* Insufficient quality of image data to allow for analysis

Where it's running

• China-Japan Frendship hospital
  Beijing, China Recruiting

Study contacts

• Study coordinator: Min Liu, PhD
• Email: mikie0763@126.com
• Phone: +86-10-84205056

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

• Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up

  This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.

  Recruiting at 16 sites Azienda Ospedaliero-Universitaria Careggi · Bagno a Ripoli, Tuscany and 15 other locations · NCT07855679

• Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE

  This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.

  Recruiting Marmara University Pendik Training and Research Hospital · Istanbul · NCT07805616

• Nailfold Capillaroscopy in Pulmonary Hypertension

  This study tests whether nailfold capillary scans correlate with invasive lung blood pressure measurements and whether these patterns change with PH treatment.

  Recruiting University of Glasgow · Clydebank, West Dunbartonshire · NCT07768644

• Right heart dysfunction in acute pulmonary embolism: can echocardiography help predict risk

  This study tests whether transthoracic echocardiography can identify right ventricular dysfunction in adults with acute pulmonary embolism to help gauge risk.

  Recruiting Sohag University · Sohag and 1 other locations · NCT07647497

• Aspiration thrombectomy with the Symphony or Prodigy devices

  This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.

  Recruiting at 13 sites Imperative Care, Inc. · Huntsville, Alabama and 12 other locations · NCT07350499

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.